Table 1.
Characteristics | Patients | |
---|---|---|
No. patients | 350 | |
No. breasts | 602 | |
Mean age at imaging, range, ± SD, years | 49.9 (27–75) ± 9.7 | |
Mean BMI, range, ± SD, kg/m2 | 28.5 (18–48) ± 5.6 | |
Type of imaging performed (%) | ||
CTA | 320 (91.4) | |
MRA | 30 (8.6) | |
Breast cancer type (%)* | ||
Invasive (infiltrating) ductal carcinoma | 200 (33.2) | |
Ductal carcinoma in situ | 47 (7.8) | |
Invasive (infiltrating) lobular carcinoma | 31 (5.1) | |
Lobular carcinoma in situ | 8 (1.3) | |
Undifferentiated | 1 (0.2) | |
Malignant phyllodes | 1 (0.2) | |
Other | 6 (1.0) | |
No cancer | 231 (38.4) | |
Information not available | 77 (12.8) | |
Genetic predisposition (%) | ||
BRCA+ | 43 (12.3) | |
BRCA− | 119 (34.0) | |
Other mutation | 12 (3.4) | |
Genetic study not performed | 176 (50.3) | |
Family history of breast cancer (%) | 139 (39.7) | |
Breast reconstruction (%) | ||
DIEP flap | 334 (95.4) | |
Implants | 4 (1.2) | |
Not performed† | 12 (3.4) | |
Breast reconstruction laterality (%) | ||
Bilateral | 244 (69.8) | |
Unilateral | 94 (26.8) | |
Not performed to date† | 12 (3.4) | |
Prophylactic mastectomy (%)* | 231 (38.4) | |
Breast reconstruction timing (%) | ||
Delayed | 140 (40.0) | |
Immediate | 135 (38.6) | |
Immediate + delayed | 57 (16.3) | |
Not reconstructed | 12 (3.4) | |
Information not available | 6 (1.7) |
In number of breasts (n = 602).
Not performed due to being lost to follow-up, not a candidate for DIEP reconstruction after imaging, patient preferences or incidental findings on imaging.
BMI, body mass index.